None
Former Penn State assistant coach accepts head-coaching spot at Southern Miss
The Brightcom Group, shares of which are currently suspended for trading due to non-compliance, said in its "weekly update" that the trading suspension revocation process may advance, once it declares its April-June quarter results for the current financial year on Saturday, November 30, 2024. NSE It had earlier mentioned that it is confident of its trading suspension being revoked by the BSE and the NSE "well before" December 14, 2024. "The focus remains on making sure full trading resumes as quickly as possible," the Brightcom Group said in its weekly update. Brightcom Group shares have been suspended for regular trading for over five months now, leaving over 6.5 lakh small shareholders in the lurch. They only trade in the trade-for-trade segment and are categorized in the 'Z' group of stocks, where trading takes place only on the first trading day of the week. The weekly update also mentioned that the Group's appeal at the Securities Appellate Tribunal (SAT) will be heard on December 4. Earlier this year, the SAT had dismissed Brightcom Group's appeal against the order issued by market regulator Securities and Exchange Board of India (SEBI), which barred former Chairman PS Reddy and CFO Narayan Raju from holding key managerial positions. The recent hearing addressed the specific regulatory orders related to asset impairment and preferential issues, not the broader compliance or revocation process. Brightcom Group also recently conducted its Annual General Meeting (AGM), where it said all the proposals were passed and also conducted an investor call, the transcript for which will also be shared to the exchanges. During the January-March quarter of financial year 2024, Brightcom Group's revenue fell to ₹704 crore from ₹1,367 crore during the same quarter last year, but increased from the ₹453 crore it reported in the October-December period. It also reported a net profit of ₹37.45 crore, according to its P&L statement, compared to a loss of ₹24 crore in the previous quarter.
NoneHyundai Motor and Kia's Robotics LAB Announce Plans to Launch 'X-ble Shoulder' at Wearable Robot Tech DayIn Adam J. Graves and Suchitra Mattai’s Anuja , resilience in the face of hardship is the central heartbeat. The short film, doubling as both a heartwarming tribute to sisterhood and as a social awareness campaign about the effects of unchecked child labor, focuses on Anuja (Sajda Pathan), a young girl who lives with her older sister, Palak (Ananya Shanbhag), in Delhi, India as they live in poverty working long hours at a garment factory. One day, when a social worker (Gulshan Walia) arrives at the factory to expose the overseer for working Anuja illegally, he proposes that the youngster take part in an exam that will get her into a boarding school to better her chances of escaping her station. The two sisters are then tasked to raise money for the participation fee while Anuja decides the fate of her future. Fresh off of Academy Award voting precursor wins for best live-action short at the HollyShorts Film Festival in Los Angeles and the grand prize winner at the New York International Short Film Festival, the short film has also garnered support from Indian filmmakers Mindy Kaling and Guneet Monga Kapoor . Below, Graves talks to Deadline about his inspirations, working with young actors and raising awareness about the plights of child labor. DEADLINE : You have a varied background, from your PhD in philosophy to your various studies within South Asian culture and language. You also are a teacher. I’m curious how your expertise helped shape you as a filmmaker and come up with the origins of Anuja. ADAM J. GRAVES: I did my undergraduate degree in South Asian studies and wrote a master’s thesis on Abhinavagupta, the 12th-century Kashmir Shaivism philosopher who wrote in the domain of Indian Hindu philosophy known as Tantra. But it’s not [the same as the] new age Tantrism today. His work had very little to do with that. I spent about five or six years of my life going back and forth between India and I studied at Banaras Hindu University. I was always fascinated with Indian culture and literature, especially philosophy. And so, I knew that I wanted to film in India. It’s such a visually beautiful place. The energy and the culture are so rich. My wife is of South Asian descent. She played a large role in shaping this project and inspiring it, quite frankly. Her family’s history is rather complicated. Her ancestors go back to a place called Gorakhpur in northern India. They were brought by the British to Guyana as indentured laborers after the British abolished slavery. They turned to indentured servitude, and because of that family history, we’ve always been interested and concerned with labor issues. So that was the origins of the project, just bringing these two things together, wanting to shoot in India, and also having a concern with labor issues. And we were coming out of the pandemic, and everybody was talking about supply chains. But they were talking about the consumer end of supply chains. And we’re like, “Well, what’s happening on the other end? Not just here, but what’s going on where in terms of the production?” We came across a statistic that one in 10 kids, globally, is engaged in child labor, which was shocking to us because that seemed like an incredibly high number, 160 million kids. And we thought, “Well, how many films, really, can we think of off the top of our head that deal with those kids or with kids living in that context?” And we couldn’t think of that many. So, we thought this would be an interesting way to anchor the story. Let me just say that I feel that it’s an incredible privilege to be able to make film. And if you can, if you have the opportunity, then why not use the lens as a window that you can provide people into another world and provide people an experience that will allow them to empathize with people who don’t maybe have it as well off as some of us. Principally, I feel a film has to be a work of art that speaks to some of the universal aspects of human existence. DEADLINE : While your short film does examine the life of child labor, it also has levity and this balance between resilience and joy amongst the struggle. Anuja has her sister and even strangers who care about her future and safety. Why was it important to add this layer to the film? GRAVES: Two things happened. One, while we were doing research for the film and we were meeting with the children who were either working or formally working, it was just so evident to us, early on, that we had to pay tribute to the joy that these kids were able to find in really difficult circumstances. The kind of energy, creativity, and resilience was palpable when we met with these kids, so we wanted to make sure that we built that into the film and become part of the story. It wasn’t just a doom and gloom story about kids who had it tough, but it was also a story that highlights the resilience and the spirit of these children. Secondly, we wanted to make sure the film was something these kids would enjoy. I mean, they kind of became the audience for us as we were kind of crafting this story. We wanted to make sure that it wasn’t just going to be a film. We knew that we were going to share it with them. And we want it to be a gift to them in some way, something that they would watch and enjoy. And that meant it had to be more than just a dark, dramatic portrait of life in a factory. DEADLINE : You worked with Salaam Baalak Trust, which is also where you ended up finding the lead actress. What was the collaboration process like? GRAVES: It developed organically while we were researching. We were working with a number of nonprofits actually in and around Delhi. And the Salaam Baalak Trust’s mission seemed to resonate with what we were trying to do with the film. I think that has to do with the fact that it’s a nonprofit founded by the director Mira Nair’s family. Mira Nair is a towering figure in global cinema. She’s of Indian origin, but she’s lived in Uganda, New York, and everywhere else. So, I don’t want to say she’s an Indian filmmaker because she’s a person of the world. But she made a movie, Salaam Bombay! , about street children in Bombay, in what is now Mumbai. And after her mother saw the film, she was inspired to start a nonprofit. So, with the help of Mira, they established this organization that provides a home and educational opportunities for street children. Maybe I’m speculating, but I think because a film inspired this nonprofit, that organization recognized that art, especially performing arts, can be a really important vehicle for cultivating a kid’s sense of self-worth and confidence. So, they have a really robust theater program within this orphanage. So, when we were developing the film, they understood right away what we were trying to do. On the other hand, some of the other organizations thought we were trying to make a documentary about them. And because they have a theater program, they had a lot of kids who they wanted to submit. We felt early on that, “OK, we have to try. We know it’s going to be difficult, but we have to try to cast directly from the community.” Then the Salaam Baalak Trust was an organization that was open. Their kids were excited to be featured in a film. So, when we were casting, we looked at self-tapes from all over India, especially a lot from Mumbai and the film industry, kids who already had a film background. But we also received a lot from the Salaam Baalak Trust and from a couple of other nonprofits. They’re also located in the Paharganj, one of two neighborhoods that are up against each other in Old Delhi. I knew I wanted to film there, and one of the factories we filmed was just north of there. The movie theater we wanted to film in was north of there as well. They helped us with everything from locations to research. Ideally, we want to use the film as a tool to raise awareness about child labor, but also, hopefully, gets money for the Salaam Baalak Trust. They do great work. DEADLINE : Talk about casting Sajda Pathan and Ananya Shanbhag as sisters. They are so great onscreen. GRAVES: We were so lucky, Sajda. She lives at the Salaam Baalak Trust. But just not long before she was in the film, less than a year before, she was living on the streets with her older sister. She acted before she was cast in Anuja , so I can’t take credit for having discovered her or anything, but her own life experience parallels in really interesting ways that of the character of the film. And that’s pure accident. We didn’t write the script for her. But she was living without parental support on the streets and had an older sister. So, I think partly because she has an older sister, she could connect with Ananya. Ananya has a younger sibling, so when they met, they just immediately clicked. We didn’t do much in the way of rehearsals because, in my very limited experience working with child actors, sometimes the more you rehearse, the less life there is in the performance. And I think that can be true for children actors or adult actors. So, what we did is we tried to get them together. We all stayed in a hotel together, like a motel/hotel down in Paharganj and in close quarters. Sajda was staying with a social worker, and Ananya had her father along on set. We spent every moment of the day together for about three days before we started shooting. We played games, we had ice cream, and we had fun. They enjoyed each other’s company, and just very quickly became super tight. And you could see that. DEADLINE : Mindy Kaling and Guneet Monga Kapoor joined as producers on Anuja . That must have been very affirming. What do you think people are resonating with? GRAVES: These are two of my favorite people in the world, not just because they’re on board. We’ve specifically pursued them because [of what] we saw in them, their own causes, and the kinds of work they do. So, Guneet, for example, The Lunchbox is one of my favorite all-time films, an early feature film she’d worked on. And, of course, The Elephant Whisperers ... she consistently makes incredible work. It meant a lot to us to have such a towering figure within Indian cinema endorse the film and come on board and get behind it. Mindy herself has done so much for raising awareness of and foregrounding stories of women and girls. She’s also a towering figure, not just in the entertainment arts industry world but also among the Indian diaspora community. And so having her vouch for the film and having it resonate with her so much is really important. I think the thing that’s incredibly satisfying for every filmmaker who finds an audience is the sense that it somehow captures something universal, so you don’t have to come from this background to somehow be inspired by it or recognize yourself in it. We were trying to capture something about the universal features of childhood, and I think that’s one of the things that Mindy saw there, and that’s really heartwarming for us to have her on board. So, we’re super flattered, honored, and excited to see where it goes from here. DEADLINE : You’re in the conversation for the Oscars. What’s going through your mind, and what would you like people to consider? GRAVES: The two leads of the film, Sajda and Ananya, are the heart and soul of this project. I think anybody who watches films knows. Our cinematographer, Akash Raje, is incredible. I’m proud of all aspects of the film. But the heart and soul are these two incredibly gifted young actresses who gave us everything they got. And I’m just so proud of the fact that their performances are finally getting an audience, and they’re being seen. And my dream—and this is the thing that I try not to fantasize too much about—is to bring Sajda to the Oscars. I’ll tell you a silly story. When I was flying over for production, I was in LAX. I wanted to bring something for Sajda, a gift for the two actresses. But I was sick right before the trip, so I didn’t have much chance to shop. So, when I got to the airport, I wanted to bring them something from America that would be more interesting to them instead of picking something up at the Indian airport. I went into the gift shop and found a hat and sweater for Ananya, but they didn’t have anything in Sajda’s size because she’s so small. So, I found this Oscar replica statue. Of course, she had no idea what it was at the time when I gave it to her, so we had to explain it to her. But before we shot the film, I have a photo of her with this plastic Oscar, and the fact that we are now in this position talking about the real Oscar is really surreal. [This interview has been edited for length and clarity]
NoneNone
By JOSH BOAK WASHINGTON (AP) — Donald Trump loved to use tariffs on foreign goods during his first presidency. But their impact was barely noticeable in the overall economy, even if their aftershocks were clear in specific industries. The data show they never fully delivered on his promised factory jobs. Nor did they provoke the avalanche of inflation that critics feared. This time, though, his tariff threats might be different . The president-elect is talking about going much bigger — on a potential scale that creates more uncertainty about whether he’ll do what he says and what the consequences could be. “There’s going to be a lot more tariffs, I mean, he’s pretty clear,” said Michael Stumo, the CEO of Coalition for a Prosperous America, a group that has supported import taxes to help domestic manufacturing. The president-elect posted on social media Monday that on his first day in office he would impose 25% tariffs on all goods imported from Mexico and Canada until those countries satisfactorily stop illegal immigration and the flow of illegal drugs such as fentanyl into the United States. Those tariffs could essentially blow up the North American trade pact that Trump’s team negotiated during his initial term. Chinese imports would face additional tariffs of 10% until Beijing cracks down on the production of materials used in making fentanyl, Trump posted. Business groups were quick to warn about rapidly escalating inflation , while Mexican President Claudia Sheinbaum said she would counter the move with tariffs on U.S. products. House Democrats put together legislation to strip a president’s ability to unilaterally apply tariffs this drastic, warning that they would likely lead to higher prices for autos, shoes, housing and groceries. Sheinbaum said Wednesday that her administration is already working up a list of possible retaliatory tariffs “if the situation comes to that.” “The economy department is preparing it,” Sheinbaum said. “If there are tariffs, Mexico would increase tariffs, it is a technical task about what would also benefit Mexico,” she said, suggesting her country would impose targeted import duties on U.S. goods in sensitive areas. House Democrats on Tuesday introduced a bill that would require congressional approval for a president to impose tariffs due to claims of a national emergency, a largely symbolic action given Republicans’ coming control of both the House and Senate. “This legislation would enable Congress to limit this sweeping emergency authority and put in place the necessary Congressional oversight before any president – Democrat or Republican – could indiscriminately raise costs on the American people through tariffs,” said Rep. Suzan DelBene, D-Wash. But for Trump, tariffs are now a tested tool that seems less politically controversial even if the mandate he received in November’s election largely involved restraining inflation. The tariffs he imposed on China in his first term were continued by President Joe Biden, a Democrat who even expanded tariffs and restrictions on the world’s second largest economy. Biden administration officials looked at removing Trump’s tariffs in order to bring down inflationary pressures, only to find they were unlikely to help significantly. Tariffs were “so new and unique that it freaked everybody out in 2017,” said Stumo, but they were ultimately somewhat modest. Trump imposed tariffs on solar panels and washing machines at the start of 2018, moves that might have pushed up prices in those sectors even though they also overlapped with plans to open washing machine plants in Tennessee and South Carolina. His administration also levied tariffs on steel and aluminum, including against allies. He then increased tariffs on China, leading to a trade conflict and a limited 2020 agreement that failed to produce the promised Chinese purchases of U.S. goods. Still, the dispute changed relations with China as more U.S. companies looked for alternative suppliers in other countries. Economic research also found the United States may have sacrificed some of its “soft power” as the Chinese population began to watch fewer American movies. The Federal Reserve kept inflation roughly on target, but factory construction spending never jumped in a way that suggested a lasting gain in manufacturing jobs. Separate economic research found the tariff war with China did nothing economically for the communities hurt by offshoring, but it did help Trump and Republicans in those communities politically. When Trump first became president in 2017, the federal government collected $34.6 billion in customs, duties and fees. That sum more than doubled under Trump to $70.8 billion in 2019, according to Office of Management and Budget records. While that sum might seem meaningful, it was relatively small compared to the overall economy. America’s gross domestic product is now $29.3 trillion, according to the Bureau of Economic Analysis. The total tariffs collected in the United States would equal less than 0.3% of GDP. The new tariffs being floated by Trump now are dramatically larger and there could be far more significant impacts. If Mexico, Canada, and China faced the additional tariffs proposed by Trump on all goods imported to the United States, that could be roughly equal to $266 billion in tax collections, a number that does not assume any disruptions in trade or retaliatory moves by other countries. The cost of those taxes would likely be borne by U.S. families, importers and domestic and foreign companies in the form of higher prices or lower profits. Former Biden administration officials said they worried that companies could piggyback on Trump’s tariffs — if they’re imposed — as a rationale to raise their prices, just as many companies after Russia’s invasion of Ukraine in 2022 boosted food and energy costs and gave several major companies the space to raise prices, according to their own earnings calls with investors. But what Trump didn’t really spell out is what might cause him to back down on tariffs and declare a victory. What he is creating instead with his tariff threats is a sense of uncertainty as companies and countries await the details to figure out what all of this could mean. “We know the key economic policy priorities of the incoming Trump administration, but we don’t know how or when they will be addressed,” said Greg Daco, chief U.S. economist at EY-Parthenon. AP writer Mark Stevenson contributed to this report from Mexico City.Trump’s tariffs in his first term did little to alter the economy, but this time could be different
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unisys Corporation Investors to Inquire About ...
NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust Levels of Hemoglobin F mAb Dosing Well Tolerated Without Need for Supportive Care Beam on Track to Initiate Phase 1-enabling Studies by End of 2024 Beam to Host Investor Event on Dec. 8, 2024, at 8 p.m. PT SAN DIEGO, Dec. 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new data for its Engineered Stem Cell Antibody Evasion (ESCAPE) conditioning platform. Presented in an oral session at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, the data demonstrated that conditioning and in vivo selection with an anti-CD117 antibody enabled engraftment of base-edited hematopoietic stem cells (HSCs) and induced robust, durable production of fetal hemoglobin (HbF) in a non-human primate (NHP) model. ESCAPE is comprised of two investigational drug products: BEAM-103, an anti-CD117 monoclonal antibody (mAb) that is designed to suppress and/or eliminate hematopoietic stem and progenitor cells that express CD117, and BEAM-104, a cell therapy that includes an edit to the promoter region of the HBG1/2 genes intended to elevate HbF, plus an additional edit to CD117 designed to prevent binding of BEAM-103, allowing the edited cells to function normally and evade targeting by the antibody. Together, this approach aims to provide a non-genotoxic alternative to traditional transplant myeloablative conditioning. The company intends to advance BEAM-103 and BEAM-104 for development in sickle cell disease (SCD) and beta-thalassemia. “The data presented today at ASH represent a potential paradigm shift—the first in nearly 70 years—in transplant medicine,” said Giuseppe Ciaramella, Ph.D., president of Beam Therapeutics. “For decades, the field has relied on genotoxic conditioning regimens, which come with significant side effects and risks, limiting access to potentially curative therapies for many patients. With ESCAPE, we are moving toward a less toxic, more accessible approach that could expand the eligible patient population, potentially making gene editing therapies a viable option for patients with both severe and more moderate disease. These proof-of-concept data provide a strong foundation for advancing ESCAPE into the clinic, with the potential to transform transplant medicine for patients with sickle cell disease, beta-thalassemia and beyond.” In the preclinical study, conducted in the laboratory of John Tisdale, M.D., at the National Institutes of Health, CD34+ cells from three rhesus NHPs were multiplex base-edited ex vivo with BEAM-104 to introduce edits to CD117 and to HBG1/2. NHPs were then conditioned with only the BEAM-103 CD117 mAb at doses of either 10 mg/kg or 25 mg/kg, seven days prior to transplantation. Post-transplant, additional BEAM-103 treatments were administered to sustain a negative selective pressure on unedited cells. Highlights from the study include the following: Administration of the BEAM-104 edited cells to antibody-conditioned animals led to long-term engraftment. Long term engraftment of HSCs in the marrow was demonstrated by the presence of edited cells in the periphery beyond 6 months. Dosing with the BEAM-103 mAb led to rapid and near complete replacement of wild-type erythroid cells by edited cells, leading to early induction of therapeutically relevant levels of HbF. Levels of cells containing HbF reached >80% post-transplant. All NHPs achieved >40% γ-globin, a key constituent of HbF, post-transplant. Rapid and sustained reactivation of HbF post-transplant showed promise of therapeutic benefit in SCD patients. BEAM-103 dosing was well tolerated with no need for transfusions, antibiotics or additional supportive care. In contrast to busulfan conditioning, NHPs that received BEAM-103 demonstrated only minor decline in neutrophil counts and platelet levels, an expected outcome of the mAb targeting CD117 on wild-type hematopoietic stem and progenitor cells. The CD117 base-edit showed normal receptor function in vitro and in vivo. No changes to CD117 signaling, structure or expression were observed following editing. In NHP studies, normal hematopoietic reconstitution was observed post-transplantation. ASH Investor Event Information Beam will host a live and webcast investor event at 8:00 p.m. PT on Dec. 8, 2024, in San Diego to review the key presentations from this year’s ASH meeting. The event will be webcast live and can be accessed under “Events & Presentations” in the Investors section of the company's website at www.beamtx.com . The archived webcast will be available on the company's website beginning approximately two hours after the event. About Beam Therapeutics Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including, but not limited to, statements related to: the therapeutic applications and potential of our technology, including with respect to SCD, beta-thalassemia, and ESCAPE; our plans, and anticipated timing, to advance our programs; the clinical trial designs and expectations for ESCAPE; and our ability to develop life-long, curative, precision genetic medicines for patients through base editing. Each forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement, including, without limitation, risks and uncertainties related to: our ability to develop, obtain regulatory approval for, and commercialize our product candidates, which may take longer or cost more than planned; our ability to raise additional funding, which may not be available; our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates; the uncertainty that our product candidates will receive regulatory approval necessary to initiate human clinical trials; that preclinical testing of our product candidates and preliminary or interim data from preclinical studies and clinical trials may not be predictive of the results or success of ongoing or later clinical trials; that initiation and enrollment of, and anticipated timing to advance, our clinical trials may take longer than expected; that our product candidates or the delivery modalities we rely on to administer them may cause serious adverse events; that our product candidates may experience manufacturing or supply interruptions or failures; risks related to competitive products; and the other risks and uncertainties identified under the headings “Risk Factors Summary” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and in any subsequent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Contacts: Investors: Holly Manning Beam Therapeutics hmanning@beamtx.com Media: Dan Budwick 1AB dan@1abmedia.com
Adam Pemble, AP journalist whose compassionate lens brought stories to life, dies at 52Global Hyaluronic Acid-based Dermal Fillers Market Set For 11.2% Growth, Reaching $7.64 Billion By 2028
NoneAfter playoff chances slip away, Miami and Iowa State looking to regroup at Pop-Tarts BowlEarly-season college basketball tournaments are usually rife with ranked upsets, and the 2024 editions have delivered. On Wednesday, the West Virginia Mountaineers defeated the No. 3 Gonzaga Bulldogs 86-78 in overtime at the Bad Boy Mowers Battle 4 Atlantis tournament in the Bahamas. It's a monumental win for the West Virginia program and the third time in the last 72 hours a top-three team has fallen. ( No. 2 UConn lost twice on Monday and Tuesday at the Maui Invitational.) West Virginia had lost its six previous overtime games, last earning a victory in the extra frame in 2019. It's also the program's first win over Gonzaga in six tries. WEST VIRGINIA STUNS NO. 3 GONZAGA IN BATTLE 4 ATLANTIS FEAST WEEK ALWAYS GIVES pic.twitter.com/O2XaS17hlC The Bulldogs entered halftime with an eight-point lead but the Mountaineers managed to force overtime and outscored Gonzaga 17-5 from then on. Senior Ryan Nembhard was held to just seven points for Gonzaga, he had been averaging 12.2 entering the contest. Instead, Braden Huff came off the bench and led the team with 19 points. West Virginia senior Javon Small led the game with 31 points and was clutch from the free-throw line late, hitting 9-of-11. The Mountaineers shot 41.3 percent from the field and hit 11 three-pointers, which aided in their late-game surge. Gonzaga (5-1) will play in the consolation bracket the remainder of the week, but its focus will be on two ranked matchups quickly approaching. No. 8 Kentucky (Dec. 7) and No. 2 UConn (Dec. 14) will offer stiff competition for the 2024 Elite Eight qualifiers. West Virginia (4-1) advances to the Battle 4 Atlantis semifinals and face Louisville (4-1) which took down No. 14 Indiana 89-61 earlier Wednesday.Giants release quarterback Daniel Jones just days after benching him EAST RUTHERFORD, N.J. (AP) — The Daniel Jones era in New York is over. The Giants quarterback was granted his release by the team just days after the franchise said it was benching him in favor of third-stringer Tommy DeVito. New York president John Mara said Jones approached the team about releasing him and the club obliged. Mara added he was “disappointed” at the quick dissolution of a once-promising relationship between Jones and the team. Giants coach Brian Daboll benched Jones in favor of DeVito following a loss to the Panthers in Germany that dropped New York's record to 2-8. Conor McGregor must pay $250K to woman who says he raped her, civil jury rules LONDON (AP) — A civil jury in Ireland has awarded more than $250,000 to a woman who says she was raped by mixed martial arts fighter Conor McGregor in a Dublin hotel penthouse after a night of heavy partying. The jury on Friday awarded Nikita Hand in her lawsuit that claimed McGregor “brutally raped and battered” her in 2018. The lawsuit says the assault left her heavily bruised and suffering from post-traumatic stress disorder. McGregor testified that he never forced her to do anything and that Hand fabricated her allegations after the two had consensual sex. McGregor says he will appeal the verdict. Week 16 game between Denver Broncos and Los Angeles Chargers flexed to Thursday night spot The Los Angeles Chargers have played their way into another prime time appearance. Justin Herbert and company have had their Dec. 22 game against the Denver Broncos flexed to Thursday night, Dec. 19. Friday’s announcement makes this the first time a game has been flexed to the Thursday night spot. The league amended its policy last season where Thursday night games in Weeks 13 through 17 could be flexed with at least 28 days notice prior to the game. The matchup of AFC West division rivals bumps the game between the Cleveland Browns and Cincinnati Bengals to Sunday afternoon. NBA memo to players urges increased vigilance regarding home security following break-ins MIAMI (AP) — The NBA is urging its players to take additional precautions to secure their homes following reports of recent high-profile burglaries of dwellings owned by Milwaukee Bucks forward Bobby Portis and Kansas City Chiefs teammates Patrick Mahomes and Travis Kelce. In a memo sent to team officials, a copy of which was obtained by The Associated Press, the NBA revealed that the FBI has connected some burglaries to “transnational South American Theft Groups” that are “reportedly well-organized, sophisticated rings that incorporate advanced techniques and technologies, including pre-surveillance, drones, and signal jamming devices.” Red Bull brings wrong rear wing to Las Vegas in mistake that could stall Verstappen's title chances LAS VEGAS (AP) — Max Verstappen is suddenly in jeopardy of being denied a fourth consecutive Formula 1 title Saturday night. Red Bull apparently brought the wrong rear wing to Las Vegas and GPS data showed its two cars to be significantly slower on the straights than both McLaren and Mercedes, which led both practice sessions. Red Bull says it doesn’t have a replacement rear wing in Las Vegas to fix the issue and little chance of getting two flown in from England ahead of the race. Caitlin Clark to join Cincinnati bid for 16th National Women's Soccer League team WNBA star Caitlin Clark has joined Cincinnati’s bid for an expansion National Women’s Soccer League team. Major League Soccer franchise FC Cincinnati is heading the group vying to bring a women’s pro team to the city. The club issued a statement confirming Clark had joined the bid group. NWSL Commissioner Jessica Berman has said the league plans to announce the league’s 16th team by the end of the year. The league's 15th team will begin play in 2026 in Boston. Aaron Judge won't be bothered if Juan Soto gets bigger contract from Yankees than his $360M deal NEW YORK (AP) — Aaron Judge won’t be bothered if Juan Soto gets a bigger deal from the New York Yankees than the captain’s $360 million, nine-year contract. Speaking a day after he was a unanimous winner of his second MVP, Judge says “It ain’t my money” and adds "that’s never been something on my mind about who gets paid the most.” Judge led the major leagues with 58 homers, 144 RBIs and 133 walks while hitting .322. Soto batted .288 with 41 homers, 109 RBIs and 129 walks in his first season with the Yankees, then became a free agent at age 26. In a 'Final Four-type weekend,' two top-6 clashes put women's college basketball focus on West Coast LOS ANGELES (AP) — Two games featuring four powerhouse teams has put the focus in women's college basketball on the West Coast this weekend. JuJu Watkins and No. 3 Southern California host Hannah Hidalgo and No. 6 Notre Dame on Saturday. Top-ranked South Carolina visits Lauren Betts and fifth-ranked UCLA on Sunday. Both games are nationally televised and the arenas are expected to be packed. WNBA scouts will be on hand to check out some of the nation's top talent. Two teams will come away with their first losses of the season. USC coach Lindsay Gottlieb calls it “a Final Four-type weekend.” A documentary featuring Watkins will air on NBC ahead of USC's game, which leads into the Army-Notre Dame football game. Noodles and wine are the secret ingredients for a strange new twist in China's doping saga Blame it on the noodles. That's what one Chinese official suggested when anti-doping leaders were looking for answers for the doping scandal that cast a shadow over this year's Olympic swim meet. Earlier this year, reports that 23 Chinese swimmers had tested positive for a banned heart medication emerged. None were sanctioned because Chinese authorities determined the swimmers were contaminated by traces of the drug spread about a hotel kitchen. In a strange twist, the leader of China's anti-doping agency suggested this case could have been similar to one in which criminals were responsible for tainting noodles that were later eaten by another Chinese athlete who also tested positive for the drug. Athletes see climate change as threatening their sports and their health. Some are speaking up BAKU, Azerbaijan (AP) — Pragnya Mohan has been a professional triathlete for nearly a decade, but summers in her native India are now so hot that she can’t train there anymore. And she worries about a day when heat around the world kills her sport entirely. She was among athletes who spoke at the United Nations climate summit in Azerbaijan about the threat global warming poses to them, to fans and to sport itself. They described how extreme weather is making training and competing difficult or impossible. With billions of fans worldwide, some athletes and leagues are trying to get more people to care, and act, on climate change.
None